LOC645781 Activators
LOC645781 can engage distinct molecular pathways to modulate its activity. Forskolin, by directly stimulating adenylyl cyclase, raises the levels of cAMP within the cell. This surge in cAMP in turn activates protein kinase A (PKA), which can phosphorylate LOC645781 if it serves as a substrate for this kinase. Isoproterenol operates through a similar mechanism, acting as a beta-adrenergic agonist to boost adenylyl cyclase activity and hence cAMP levels, leading to PKA activation. Dibutyryl-cAMP, being a cAMP analog that readily enters cells, bypasses upstream receptors and adenylyl cyclase activation, directly activating PKA. IBMX complements these effects by inhibiting the breakdown of cAMP, further sustaining the activation signal for PKA. If LOC645781 is a target for PKA, these agents collectively ensure its continued activation through phosphorylation.
LOC645781 is also influenced by intracellular calcium concentrations. Ionomycin and A23187, both calcium ionophores, elevate intracellular calcium levels, which can activate calcium/calmodulin-dependent protein kinases capable of phosphorylating LOC645781. Similarly, BAY K8644, by acting as an L-type calcium channel agonist, enhances calcium influx, potentially leading to the activation of LOC645781 through calcium-dependent phosphorylation. PMA, on the other hand, activates protein kinase C (PKC), another kinase that may target LOC645781 for phosphorylation. Anisomycin, although primarily a protein synthesis inhibitor, can trigger stress-activated protein kinase pathways, which may include kinases that phosphorylate and change the activity of LOC645781. VU 0361737 and Zaprinast, through their modulation of secondary messenger pathways associated with mGlu4 and PDE5 inhibition respectively, can also lead to the phosphorylation and activation of LOC645781 by enhancing the activity of kinases that respond to these signaling molecules. Finally, Rolipram, by selectively inhibiting PDE4, increases cAMP levels, thus activating PKA and potentially leading to the phosphorylation of LOC645781.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that raises intracellular calcium levels. If LOC645781 is activated by calcium-dependent kinases or phosphatases, ionomycin could lead to its activation. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC), which may phosphorylate and activate LOC645781 if it is a substrate of PKC. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a beta-adrenergic agonist that activates adenylyl cyclase, leading to increased cAMP and subsequent activation of PKA. PKA then could activate LOC645781 through phosphorylation. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
3-Isobutyl-1-methylxanthine (IBMX) is a nonspecific inhibitor of phosphodiesterases, which prevents the breakdown of cAMP and cGMP, potentially enhancing PKA or PKG-mediated phosphorylation and activation of LOC645781. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
Calcimycin (A23187) is another calcium ionophore that elevates intracellular calcium, potentially activating calcium/calmodulin-dependent protein kinases that could then activate LOC645781. | ||||||
(±)-Bay K 8644 | 71145-03-4 | sc-203324 sc-203324A sc-203324B | 1 mg 5 mg 50 mg | $84.00 $196.00 $817.00 | ||
BAY K8644 is an L-type calcium channel agonist. By increasing calcium influx, it could activate calcium-dependent kinases that may phosphorylate and activate LOC645781. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP is a cell-permeable cAMP analog that activates cAMP-dependent pathways including PKA, which could lead to the phosphorylation and activation of LOC645781. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a protein synthesis inhibitor that can activate stress-activated protein kinases (SAPK) pathways. Activation of these pathways could lead to the activation of LOC645781 through stress response mechanisms. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $105.00 $250.00 | 8 | |
Zaprinast is a selective inhibitor of phosphodiesterase 5 (PDE5), which increases cGMP levels, potentially enhancing PKG activity that could phosphorylate and activate LOC645781. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram is a selective inhibitor of PDE4, leading to increased cAMP levels which may enhance PKA activity, thus phosphorylating and activating LOC645781 if it is a PKA substrate. | ||||||